Pharmaceutical - Pharmaceutical, Japan

Filter

Current filters:

PharmaceuticalJapan

Popular Filters

1 to 25 of 105 results

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

Milestone for Skyepharma as Flutiform debuts in Spain; and as Abriff in Italy

01-12-2014

UK oral and inhalation drug specialist Skyepharma says that, following regulatory approval and agreement…

AbriffFinancialFlutiformItalyJapanKyorin PharmaceuticalMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharmaSpainZambon

Daiichi Sankyo and UCB sign agreement for Vimpat in Japan

Daiichi Sankyo and UCB sign agreement for Vimpat in Japan

28-11-2014

Japanese drug major Daiichi Sankyo and Belgian drugmaker UCB have entered into an agreement to jointly…

Daiichi SankyoJapanlacosamide Tablet and InjectionLicensingNeurologicalPharmaceuticalUCBVimpat

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

Japan’s Takeda optimizes global production network

27-11-2014

Takeda Pharmaceutical has decided to focus its Osaka plant (Osaka Prefecture, Japan) to become a specialty…

GermanyJapanLupronOncologyPharmaceuticalProductionTakeda Pharmaceutical

Merck & Co submits first regulatory filing for omarigliptin, in Japan

Merck & Co submits first regulatory filing for omarigliptin, in Japan

25-11-2014

US pharma giant Merck & Co has submitted a new drug application for omarigliptin, its investigational…

DiabetesJapanMerck & CoomarigliptinPharmaceuticalRegulation

Kissei files for Japanese approval of PA21 for hyperphosphatemia

21-11-2014

Japanese mid-sized drugmaker Kissei Pharmaceutical says that a new drug application for PA21 (development…

FreseniusJapanKissei PharmaceuticalNephrology and HepatologyPA21PharmaceuticalRegulationVelphoroVifor Pharma

Takeda joins forces with GE Healthcare on liver disease research

Takeda joins forces with GE Healthcare on liver disease research

13-11-2014

Japan’s largest drugmaker Takeda Pharmaceutical has entered into an alliance agreement with UK-based…

GE HealthcareJapanNephrology and HepatologyPharmaceuticalResearchTakeda Pharmaceutical

Global melanoma market set to reach $3.6 billion by 2020

12-11-2014

The global melanoma therapeutics market was valued at $1.3 billion in 2013 and will expand at a compound…

Bristol-Myers SquibbEuropeJapanKeytrudaMarkets & MarketingMerck & CoOncologyOpdivoPharmaceuticalUSAYervoy

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

29-10-2014

Netherlands-based company Qiagen has announced a master collaboration agreement with Japanese drug major…

Astellas PharmaJapanLicensingNetherlandsOncologyPharmaceuticalQiagen

Eisai and Arena announce top line results of lorcaserin HCl with phentermine HCl

Eisai and Arena announce top line results of lorcaserin HCl with phentermine HCl

29-10-2014

Japanese drug major Eisai and Arena Pharmaceuticals have announced top-line results of a pilot study…

Arena PharmaceuticalsEisaiGastro-intestinalsJapanlorcaserinPharmaceuticalPhentermine HydrochlorideResearch

FDA accepts Eisai's supplemental New Drug Application for Fycompa in tonic-clonic seizures

FDA accepts Eisai's supplemental New Drug Application for Fycompa in tonic-clonic seizures

20-10-2014

Japanese drug major Eisai has had a supplemental New Drug Application for its in-house-discovered AMPA…

CNS DiseasesEisaiFycompaJapanPharmaceuticalRegulation

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

15-10-2014

Japanese drugmaker Kyorin Pharmaceutical and R-Pharm, one of Russia’s largest pharmaceutical producers,…

Genito-urinaryimidafenacinJapanKyorin PharmaceuticalsLicensingOno PharmaceuticalPharmaceuticalR-PharmRussiaStayblaUritos

GlaxoSmithKline takes stake in new Aspen Japanese unit

GlaxoSmithKline takes stake in new Aspen Japanese unit

09-10-2014

South African drugmaker Aspen Pharmacare says that Aspen Global Inc, a subsidiary of Aspen Holdings,…

Aspen PharmacareGlaxoSmithKlineJapanMarkets & MarketingMergers & AcquisitionsPharmaceutical

Positive new findings for Astellas’ isavuconazole in mucormycosis

Positive new findings for Astellas’ isavuconazole in mucormycosis

08-10-2014

Japanese drug major Astellas Pharma says that isavuconazole demonstrated successful outcomes in the treatment…

Antibiotics and Infectious diseasesAstellas PharmaisavuconazoleJapanPharmaceuticalResearch

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

Takeda appoints John Boslego as senior vice president of its global vaccine business unit

08-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president…

Anti-viralsBoardroomJapanPharmaceuticalTakeda Pharmaceutical

Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban

Perosphere and Daiichi Sankyo collaborate on Ph III study of PER977 with edoxaban

07-10-2014

USA-based Perosphere has entered into a third clinical trial collaboration agreement with Japanese pharma…

Cardio-vascularDaiichi SankyoedoxabanHematologyJapanPER977PerospherePharmaceuticalPortola PharmaceuticalsResearch

Teijin begins construction on $20 million site in western Japan

Teijin begins construction on $20 million site in western Japan

06-10-2014

Japanese pharma company Teijin is to build a Technology Integrated Pharmaceutics Center to leverage the…

JapanPharmaceuticalProductionTechnology Integrated Pharmaceutics CenterTeijin

Takeda responds to verdict in US Actos case; invests in vaccines firm

Takeda responds to verdict in US Actos case; invests in vaccines firm

06-10-2014

The US subsidiary of Japan’s largest drugmaker Takeda Pharmaceuticals says that in the case of Frances…

ActosAlfresa CorpDiabetesJapanLegalMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalUSAVaccine Safe CoVaccines

Daiichi Sankyo seeks wider indication for Cravit in Japan

Daiichi Sankyo seeks wider indication for Cravit in Japan

03-10-2014

Japanese drug major Daiichi Sankyo has submitted a supplemental New Drug Application (sNDA) in Japan…

Antibiotics and Infectious diseasesCravitDaiichi SankyoJapanPharmaceuticalRegulation

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

Takeda presents Phase III data for Entyvio in UC and Crohn’s Disease

02-10-2014

Japan’s largest drugmaker Takeda Pharmaceutical today announced new data from a Phase III study of…

EntyvioGastro-intestinalsJapanPharmaceuticalResearchTakeda Pharma

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

ESMO 2014: Eisai’s lenvatinib could revolutionize treatment of rare thyroid cancer

30-09-2014

An orphan drug could offer real hope to patients with rare thyroid cancer, Japanese drugmaker Eisai revealed…

EisaiInterviewsJapanlenvatinibOncologyPharmaceuticalResearch

1 to 25 of 105 results

Back to top